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Abstract
Subclinical infection of murine norovirus (MNV) was detected in a mixed breeding group of WT 
and Stat1−/− mice with no outward evidence of morbidity or mortality. Investigations revealed the 
presence of an attenuated MNV variant that did not cause cytopathic effects in RAW264.7 cells or 
death in Stat1−/− mice. Histopathological analysis of tissues from WT, heterozygous and Stat1−/− 
mice revealed a surprising spectrum of lesions. An infectious molecular clone was derived directly 
from faeces (MNV-O7) and the sequence analysis confirmed it was a member of norovirus 
genogroup V. Experimental infection with MNV-O7 induced a subclinical infection with no 
weight loss in Stat1−/− or WT mice, and recapitulated the clinical and pathological picture of the 
naturally infected colony. Unexpectedly, by day 54 post-infection, 50 % of Stat1−/− mice had 
cleared MNV-O7. In contrast, all WT mice remained infected persistently. Most significantly, this 
was associated with liver lesions in all the subclinically infected WT mice. These data confirmed 
that long-term persistence in WT mice is established with specific variants of MNV and that 
despite a subclinical presentation, active foci of acute inflammation persist within the liver. The 
data also showed that STAT1-dependent responses are not required to protect mice from lethal 
infection with all strains of MNV.
INTRODUCTION
Understanding the mechanisms of viral persistence of non-integrating RNA viruses will 
facilitate ultimately their control. Persistence of members of the family Caliciviridae has 
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been reported after infection with feline calicivirus (FCV), rabbit haemorrhagic disease virus 
(RHDV), and human and murine norovirus (HuNoV and MNV) (Capizzi et al., 2011; Coyne 
et al., 2006; Forrester et al., 2003; Hsu et al., 2006; Siebenga et al., 2008; Thackray et al., 
2007). Studies on HuNoV persistence have focused on mechanisms of viral evolution, 
antigenic variation and receptor switching to allow persistence in the population, but if and 
how ‘within-host’ persistence occurs is not understood clearly. Persistence of FCV and 
RHDV is thought to occur by gradual mutation driven by the immune response, but 
recombination between strains and reinfection may also occur (Coyne et al., 2007; Forrester 
et al., 2008).
MNV has been reported to persist in both immunocompromised and immunocompetent 
mice, and persistent infection can occur in immunocompetent hosts despite robust 
seroconversion (Hsu et al., 2006; Karst et al., 2003; Thackray et al., 2007). Acute and 
persistent strains of MNV belong to the same genogroup (V), and serogroup and systemic 
infection occurs with both types, with spread to the spleen, liver and lungs as well as other 
organs (Hsu et al., 2006; Thackray et al., 2007). A role for antibodies and T-cells in the 
clearance of acute MNV from tissues and the intestine has been demonstrated (Chachu et 
al., 2008a, b), but persistent MNV strains are less well characterized, and there are few 
comparisons between acute and persistent strains (Kahan et al., 2011; Nice et al., 2013).
How persistent norovirus infection is maintained is unclear. Changes in surface antigens 
may enable evolving viral progeny to evade the immune system, facilitating their persistence 
in the host. This has been shown for FCV and MNV during chronic infection where 
mutations occur in areas predicted to be important for immune recognition (Arias et al., 
2012; Johnson, 1992; Radford et al., 1998). Impairment of immune cell function may be 
another way in which virus can persist. MNV replicates in macrophages and dendritic cells 
and, like many viruses that infect antigen-presenting cells, may also impair the activation of 
T-cells (Tomov et al., 2013) and B-cells (Oldstone, 2006; Wobus et al., 2004). Studies with 
two persistent strains of MNV have implicated colonic tropism in persistent infection of 
immunocompetent mice; however, the immunopathological consequences of infection by 
these viruses have not been established (Arias et al., 2012; Nice et al., 2013).
Here, we report on the identification and characterization of a variant of MNV (MNV-O7) 
derived from a small group of mixed breeding animals consisting of Stat1−/− and WT mice 
that had no clinical abnormalities or increased mortality. Surprisingly, all animals in this 
group were infected subclinically. Virus growth was noncytopathic in vitro. Furthermore, 
although experimental infection of immunocompetent and Stat1−/− mice was subclinical, 
histopathology revealed a progressive, subclinical multifocal hepatitis. An infectious 
molecular clone was derived directly from faeces, which recapitulated this pathology. 
Interestingly, infection of immunocompetent mice showed that all animals had long-term 
persistence of MNV-O7, whilst resolution and clearance occurred in 50 % of Stat1−/− mice. 
Here, we report on the characterization of a non-pathogenic MNV strain in Stat1 knockout 
mice with direct derivation of an infectious molecular clone from faeces.
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RESULTS AND DISCUSSION
Natural MNV-O7 infection is subclinical in Stat1−/− mice
MNV was first described as an acute infection with mortality and morbidity apparent in 
Stat1−/− mice, persistent subclinical infection in Rag−/− mice, and acute subclinical infection 
in WT mice (Karst et al., 2003). STAT1 (signal transducer and activator of transcription-1) 
is a central molecule in signalling from all IFN receptors and as such is key in inducing the 
innate immune response antiviral pathways. RAGs are the recombination activating 
enzymes involved in B- and T-cell receptor rearrangement, and mice without the genes for 
these proteins do not have an adaptive immune response. It was therefore proposed by Karst 
et al. (2003) that the IFN pathway is important in controlling the level of MNV infection, 
but that adaptive immune responses are important in clearing the virus. MNV has also been 
reported as causing a persistent infection in immunocompetent mice (Godinez et al., 2009; 
Hsu et al., 2006, 2007; Karst et al., 2003; Manuel et al., 2008; Thackray et al., 2007). To 
date, however, there has been no report of the consequences of subclinical and persistent 
MNV infection in Stat1−/− mice.
A mixed colony of Stat1−/− mice with WT and heterozygous mice was found to be 
seropositive for MNV by diagnostic ELISA. However, all mice were healthy and the high 
morbidity or mortality seen previously in Stat1−/− mice (Karst et al., 2003; Wobus et al., 
2004) was not evident. The genotype of the mice was confirmed using two different sets of 
published primers (Agrawal et al., 2007; Mohan et al., 2000) (data not shown). Surprisingly, 
at necropsy all the Stat1−/−, 63 % of the heterozygous and none of the WT mice had 
splenomegaly. In addition, Stat1−/− mice had multifocal, round slightly raised pale foci 
throughout the liver parenchyma (data not shown). Occasionally, the mesenteric lymph 
nodes were also enlarged, but no other gross abnormalities were detected.
Histopathology revealed lesions in the liver (Stat1−/−, Fig. 1b, c; heterozygous and WT 
mice, Fig. S1, available in JGV Online), spleen, intestine and lungs (data not shown); these 
varied from normal to mild/moderate foci of inflammation and in 33 % of the mice 
multifocal to diffuse necrosis. A vasculitis (Fig. S1a) with occasional mild inflammatory 
foci occurred in the liver parenchyma of 15 % of the WT and 56 % of the heterozygous mice 
(data not shown), whilst the livers of 22 % of the heterozygous and 83 % of the Stat1−/− 
mice showed more severe multifocal to diffuse areas of inflammation often accompanied by 
necrosis and fibrosis (Figs 1c and S1b). Lesions were present in the spleens, and varied from 
red pulp hyperplasia and activation of the white pulp in both WT and heterozygous mice (20 
and 38 %, respectively) to multifocal inflammation and necrosis in 50 % of the heterozygous 
and all of the Stat1−/− mice (data not shown). In the lungs, 73 % of the Stat1−/− mice had 
evidence of pneumonia with focal to multifocal perivascular inflammatory cell infiltrates 
(Fig. 1d).
In WT mice naturally infected with this strain of MNV (referred to as MNV-O7), 
enlargement of Peyer’s patches with increased germinal centres was observed. In Stat1−/− 
mice, mesenteric lymph nodes were enlarged with expanded, hyperplastic germinal centres 
(data not shown).
Shortland et al. Page 3
J Gen Virol. Author manuscript; available in PMC 2015 January 29.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Direct isolation of a full-length molecular clone of MNV-O7 - a unique MNV strain
In order to characterize the virus without adaptation in tissue culture, an infectious full-
length molecular clone called MNV-O7mc was derived directly from faeces of a Stat1−/− 
mouse. Western blotting of the supernatant of molecular clone-transfected cells revealed 
expression of MNV-O7mc RNA polymerase (Fig. S2). Reverse transcriptase (RT)-PCR 
using RNA extracted from RAW264.7 cells infected with supernatant from the transfection 
produced a strong band at 186 bp as expected for MNV-1 and MNV-O7 (data not shown). 
This confirmed in vitro that the reverse genetics system had produced infectious virus.
MNV-O7mc was sequenced. A phylogenetic tree of the predicted amino acid sequences of 
VP1 showed that MNV-O7 clustered with other MNV strains in genogroup V separate from 
norovirus genogroups I, II, III and IV (data not shown), in agreement with previous reports 
(Thackray et al., 2007). The predicted VP1 amino acid sequence of MNV-O7 was <11 % 
divergent compared with other MNV strains, which supported the classification of MNV-O7 
within genogroup V. Phylogenetic analysis of MNV genomic nucleotide sequences showed 
MNV-O7 to cluster with MNV-O1 (isolated from a WT mouse in the same colony), on a 
branch separate from other MNV strains, but closely related to two German isolates (GV/
CR18/2005/DEU and Berlin/05/O6/DE) and a South Korean isolate (MNV3/K4/2009/
Korea) (Fig. 1a). This most probably reflects movement of mice between breeding and/or 
experimental animal facilities. MNV-O7 was identified as a unique strain as it diverged by 
>3 % from all other MNV strains (Thackray et al., 2007).
MNV-O7 had four ORFs characteristic of MNV (Thackray et al., 2007). Compared to 
MNV-1, MNV-O7 ORF2 had 178 nt differences (Fig. S3) corresponding to 17 aa 
differences, including a codon (CAA) deleted at nt 6676 as has been observed for CR18 
(Thackray et al., 2007). Phylogenetic analysis also showed CR18 to be related closely to 
MNV-O7 (Fig. 1a). The majority of the differences seen were in the P domain of the capsid 
(aa 229–537), which is consistent with the P domain being the most variable (Thackray et 
al., 2007). However, the differences were spread across the P region and not restricted to the 
P2 domain (aa 278–415) of the capsid. MNV-O7 had a glutamic acid at aa 296 in the P2 
region of VP1, which is known to be associated with avirulence in Stat1−/− mice (Bailey et 
al., 2008). The majority of MNV strains also have a predicted glutamic acid in this region of 
VP1, with only MNV-1 and its derivatives containing lysine at this position. The epitope for 
the neutralizing mAb A6.2 is also conserved in MNV-O7 (leucine at residue 386) (Katpally 
et al., 2008; Lochridge & Hardy, 2007; Taube et al., 2010).
Comparison of ORF1 between MNV-O7 and MNV-1 revealed 80 aa differences (Fig. S3). 
These included a glutamic acid at position 94 of NS1/2 that is associated with growth in the 
proximal intestine in the persistent strain CR6 (Nice et al., 2013). ORF3 had 21 and ORF4 
24 aa differences between MNV-O7 and MNV-1 (Fig. S3).
To prove that the MNV-O7mc was infectious in vivo, three Stat1−/− and three WT mice 
received 1×104 RNA copies of MNV-O7mc, whilst another three Stat1−/− and three WT 
mice were mock inoculated. The mice were observed daily (for 7 days) and clinical signs 
were absent. A diagnostic RT-PCR for MNV carried out on faecal RNA collected pre-
infection and at day 7 post-infection (p.i.) showed no product in the control animals before 
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and after inoculation, and no product in the challenged mice before infection with MNV-
O7mc (data not shown). Importantly, the faeces were virus-positive at day 7 p.i. for almost 
all animals inoculated with MNV-O7mc (three of three WT and two of three Stat1−/− mice, 
data not shown). A MNV RT-quantitative (q)PCR assay on the samples showed that all of 
the challenged mice were infected, with viral titres in faeces ranging from 4×104 to 4×105 
copies ml−1. The single Stat1−/− mouse that was negative by diagnostic RT-PCR had a low 
viral copy number.
A separate group of WT mice was also infected with MNV-O7mc and the virus caused 
persistent infection (three of three mice shedding virus in faeces at day 30 p.i.).
The filtered supernatant of faecal homogenate from the original MNV-O7-positive Stat1−/− 
mouse was incubated with RAW264.7 cells for 4 days, yet no cytopathic effects (CPEs) 
were visible (Fig. S4b), despite an increase in viral RNA measured by RT-qPCR. MNV-1 
did cause CPEs (Fig. S4c). At day 4 p.i., viral RNA levels with MNV-O7 as detected by RT-
qPCR were similar to MNV-1 levels. The MNV-O7mc stock grown in RAW264.7 cells was 
also noncytopathic (data not shown).
Our data illustrate that full-length amplification of infectious MNV without growth in cell 
culture is possible and can provide a method of characterizing non-cytopathic viruses. This 
method of producing infectious virus limits the mutations that might be caused by tissue 
culture passage and these are known to attenuate MNV-1 in Stat1−/− mice (Bailey et al., 
2008; Wobus et al., 2004). There has also been concern expressed that experimental 
infections showing persistence of MNV have only been carried out with virus grown in 
tissue culture that may select for this trait (Hsu et al., 2007). These concerns have been 
addressed here to show that a directly isolated virus was attenuated in Stat1-knockout mice 
and caused persistent infections in immunocompetent mice. Production of a fulllength clone 
by RT-PCR may also induce RT- and PCR polymerase-related mutations; however, these 
can be minimized by the use of a proofreading PCR enzyme, as was used here.
Control of MNV is not dependent on STAT1 responses
MNV-1 was first identified because it caused mortality in Rag2−/−Stat1−/− mice and this was 
shown to be due to the lack of STAT1. This finding implied an important role for STAT1-
mediated immune responses in the control of MNV infection in mice (Karst et al., 2003). 
Here, Stat1−/− and WT mice were infected with 108 RNA copies of MNV-1 and MNV-O7. 
All virus-infected animals were positive for MNV RNA in the faeces at day 5 p.i. (Table 1). 
The animals were observed daily for any clinical signs. There was a decrease in body weight 
in Stat1−/− mice infected with MNV-1 compared with mock-infected Stat1−/− mice at days 6 
and 7 p.i. (P<0.01, Fig. 2). This confirmed that MNV-1 infection was virulent in Stat1−/− 
mice. There was no difference in the weight gain between MNV-O7-infected Stat1−/− mice, 
MNV-O7- and MNV-1-infected WT mice, and mock-inoculated mice on the same genetic 
background. At day 5 p.i., Stat1−/− mice infected with MNV-1 showed a hunched posture, 
piloerection, subdued behaviour, distended abdomens and reduced faecal output, and by day 
7 p.i. these mice had been euthanized due to the clinical signs, as expected (Karst et al., 
2003). In contrast, no clinical signs were observed in mock- or MNV-O7-infected Stat1−/− 
mice, nor in mock- or virus-infected WT mice. This supports the hypothesis that MNV 
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pathogenicity in Stat1−/− mice is dependent on the viral strain. It also agrees with previous 
reports where 129 mice infected acutely by the intracerebral, intranasal and peroral routes 
with MNV-1 showed no clinical signs (Karst et al., 2003). Other studies have shown faecal 
inconsistency soon after MNV-1 infection, but this has not been replicated with other MNV 
strains such as MNV-3 (Kahan et al., 2011; Mumphrey et al., 2007).
A diagnostic RT-PCR was performed on faecal and tissue samples from the animals 
remaining on study at day 54 p.i. (Table 1). No viral RNA was detected in the faecal 
samples from any of the Stat1−/− mice infected with MNV-O7, although viral RNA was 
isolated from the spleens and livers of ~50 % of these mice. However, viral RNA was found 
in the faeces, liver and spleen from all the WT mice infected with MNV-O7. These data 
indicated that MNV-O7 was only secreted actively from persistently infected WT mice, with 
Stat1−/− mice clearing virus RNA from the gut more rapidly than from the spleen and liver. 
Subsequent studies in our laboratory confirmed the presence of MNV-O7 RNA in the 
caecum, colon and mesenteric lymph node of chronically infected WT mice (data not 
shown). Infections with other persistent strains of MNV (MNV-2, -3 and-4) also produced 
detectable RNA in the faeces, mesenteric lymph node, jejunum, caecum and colon at 8 
weeks p.i. (Arias et al., 2012; Hsu et al., 2006). In C57BL/6 mice, viral RNA has been 
detected in faeces for up to 9 months p.i. with MNV strains CR1, CR3, CR6 and CR7, and 
in addition in the mesenteric lymph nodes and distal ileum for CR1 and CR3 (McFadden et 
al., 2013; Thackray et al., 2007). However, in these studies no significant live viral titres 
were found. A discrepancy in virus detection using either RT-PCR or live virus assays has 
been reported, and could be due to the limit of live viral detection, the viral genome copy 
number being much higher than the actual number of replication-competent infectious virus 
particles or neutralizing antibody interfering with virus isolation (Thackray et al., 2007).
All the WT mice infected with MNV-1 had cleared virus from faeces and tissues by day 54 
p.i. (Table 1), which is in agreement with previous studies (Hsu et al., 2006; Karst et al., 
2003). The inability of MNV-1 to cause persistent infection has now been attributed to the 
presence of aspartic acid at position 94 of NS1/2. This amino acid is glutamic acid in other 
isolated MNV strains, including MNV-O7. The MNV-1 mutation may have arisen by in 
vitro tissue culture adaptation or adaptation in vivo by intracerebral passage (Thackray et al., 
2007).
Taken together, we have shown that control of MNV infection was not dependent on STAT1 
responses, as mice without the Stat1 gene survived MNV-O7 infection. Normal IFN-induced 
responses were only important in controlling levels of replication with MNV-1, as has been 
shown previously (Karst et al., 2003). It was surprising to find that MNV-O7 was cleared 
from all faecal samples and the tissues of ~50 % Stat1−/− mice during chronic infection. 
Although STAT1 is the major transcription factor used to signal from IFN receptors, it is not 
the only factor used (Gil et al., 2001; Malmgaard et al., 2002; Ramana et al., 2002; Shresta 
et al., 2005). It may also mean that important regulators of immune signalling, e.g. the 
SOCS (suppressor of cytokine signalling) proteins, are not induced and so aberrant cytokine 
responses may be induced in these mice. Differences in cytokine responses between Stat1−/− 
and WT mice would be worth exploring to determine which gene or genes may be driving 
the clearance of MNV in this genetic background.
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Gross spleen and liver pathology in MNV-O7-infected mice
After acute infection, splenomegaly was evident in MNV-1-infected Stat1−/− mice, 
characterized by decreased coloration and an increase in length (P<0.05) compared with 
mock-infected and MNV-O7-infected mice (Fig. S5). There were no differences in the 
spleen size between mock-infected and MNV-1- or -O7-infected WT mice and mock-
infected and MNV-O7-infected Stat1−/− mice. Similarly, there were no differences in size or 
gross pathology of the livers between mock-infected and virus-infected WT and Stat1−/− 
mice (data not shown). However, at day 54 p.i. (i.e. chronic infection), the spleens from 
Stat1−/− mice infected with MNV-O7 were elongated (P<0.05) compared with mock 
infected Stat1−/− mice and WT mice infected with MNV-O7 (Fig. S6). There was no 
significant difference in the spleen length between the other animal groups. The spleens 
from MNV-O7-infected Stat1−/− mice had pale foci. At this time point, there was no 
difference in the size of the intact livers; however, pale foci were seen in the livers from 
Stat1−/− mice infected with MNV-O7 (data not shown).
Previous studies have shown that spleens from Stat1−/− mice infected with MNV were 
enlarged grossly and that sometimes the livers had pale spots, but whether these changes 
were acute or chronic was unclear (Ward et al., 2006). The lack of gross pathological lesions 
after MNV infection in immunocompetent mice is in agreement with other studies (Perdue 
et al., 2007).
Histopathological lesions in MNV-O7-infected mice
Both the MNV-O7mc and tissue culture-derived virus caused histopathological lesions in 
the liver (Figs 3b and 4e) and spleen (Fig. 3d) of Stat1−/− mice after acute infection, whilst 
mock-inoculated mice showed no liver or splenic pathology (Figs 3a and 4d, liver; Fig. 3c, 
spleen). The livers of Stat1−/− mice infected with MNV-O7mc had prominent cannuli and an 
increase in inflammatory cells (Fig. 3b), and the spleens had areas of coagulative necrosis 
and pyknotic debris suggestive of apoptosis (Fig. 3d). At this acute time point, WT mice 
infected with MNV-O7mc and tissue culture-derived MNV-O7 had no histopathological 
lesions (Fig. 4b).
As in MNV-O7-infected immunocompetent and Stat1−/− mice, acutely MNV-1-infected 
immunocompetent mice had mild-to-moderate reactive hyperplasia in the spleens (data not 
shown). At this time point the spleens from MNV-1-infected Stat1−/− mice had diffuse 
reactive hyperplasia, expansion of the red pulp and activation of white pulp with the 
presence of pyknotic debris, suggesting apoptosis. In addition, two of these mice had focal 
areas of coagulative necrosis with a neutrophilic inflammatory infiltrate in the spleen (Fig. 
S7). There was moderate vasculitis and infiltration of inflammatory cells, mainly 
lymphocytes, in the liver from Stat1−/− mice infected with MNV-1. Coagulative necrosis 
accompanied by inflammation was also seen in the livers from two of these animals (Fig. 
4f).
WT mice were kept until day 54 p.i. and no liver (Fig. 5a, mock; c, MNV-1) or splenic 
pathology (Fig. S8) was seen in mock- or MNV-1-infected mice.
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After chronic infection (days 30–54 p.i.), no histopathological lesions were observed in the 
spleens of mock-infected WT or Stat1−/− mice, nor in MNV-1- or MNV-O7-infected WT 
mice (Fig. S8). Interestingly, at this late time point in the spleens from Stat1−/− mice 
infected with MNV-O7, there was red pulp hyperplasia and mild lymphoid hypoplasia and 
moderate to severe multifocal coalescing areas of inflammation with coagulative necrosis 
and fibrosis (Fig. S8). As expected, there was no histopathological lesions in the livers from 
mock-infected WT (Fig. 5a) and Stat1−/− (Fig. 5d) mice. There were also no 
histopathological lesions in the livers from MNV-1-infected WT mice (Fig. 5c) at day 54 
p.i.. In contrast, there were focal areas of mild perivascular inflammation consisting mainly 
of lymphocytes in the livers from MNV-O7-infected WT mice (Fig. 5b), whilst in Stat1−/− 
mice infected with MNV-O7 there were large multifocal to coalescing areas of inflammation 
(mostly neutrophils), necrosis and fibrosis in the livers (Fig. 5e) – evidence of persistent 
ongoing inflammation caused by MNV-O7.
Histological lesions were scored in the liver (Fig. 6) and spleen (data not shown) at days 5 
and 54 p.i. The lesion score in MNV-1-infected Stat1−/− mice was increased when compared 
with mock-infected Stat1−/− mice in the liver (P<0.01, Fig. 6a) and spleen (P<0.01) during 
acute infection. There was also an increase in lesion score in the livers of Stat1−/− mice 
infected with MNV-O7 (P<0.05, Fig. 6a). Very few lesions were seen in WT mice with 
either virus at acute time points (Fig. 6a). During chronic infection, there was an increase in 
the lesion scores in MNV-O7-infected Stat1−/− mice in the liver (P<0.05, Fig. 6b) and 
spleen (P<0.05) when compared with mock-inoculated Stat1−/− mice. There was also a 
smaller but significant increase in liver lesions in MNV-O7-infected WT mice (P<0.05, Fig. 
6b), whilst MNV-1-infected WT mice showed no increase in lesion score compared with 
mock-infected animals at late time points.
In a study of naturally infected immunodeficient mice, MNV infection caused hepatitis, 
focal interstitial pneumonia, peritonitis and pleuritis (Ward et al., 2006). However, that 
study could not determine if the lesions were present after chronic infection because only 
naturally infected mice were investigated and so the time after infection was not known. In 
another study, MNV infection of immunocompetent Swiss Webster sentinel mice did not 
cause gross pathology; however, 80 % of the livers from 67 animals had small inflammatory 
foci, although this inflammation was not severe enough to be called hepatitis (Perdue et al., 
2007). No lesions were observed in the small intestine or spleen of animals in this study, but 
again the time of infection was unknown. Perdue et al. (2007) also showed that viral capsid 
antigen was present in liver lesions and Kupffer cells, and also in the mesenteric lymph 
nodes of these mice, suggesting active infection.
In summary, a subclinical variant of MNV was derived from Stat1−/− mice and characterized 
genetically. Virus was generated directly from infected faeces by reverse genetics, and the 
molecularly cloned variant confirmed subclinical but ongoing pathology in Stat1−/− mice 
and persistent infection in WT mice.
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METHODS
Genotyping
Mouse genomic DNA was extracted with the DNeasy Blood and Tissue Kit (Qiagen) 
following the manufacturer’s instructions. Two separate PCRs were used to confirm the 
genetic status of the mice used. The first PCR (Agrawal et al., 2007) distinguished WT, 
heterozygous and Stat1−/− mice using three different primers: primer SF2992 (forward 
primer ctaccagagtatctgcctagac), primer SR3318 (reverse primer cctctcaaccttcctgacacc) and 
primer NeoR3392 (reverse primer cgccgctcccgattcgcagcgcatcgc). The second PCR used two 
primers (SF2893: forward primer gagggaatgtgtgatgggtcagg; SR4006: reverse primer 
attctccagagaaaagcggctgt) and distinguished mice bearing the Stat1 gene (WT and 
heterozygous mice) from knockout mice (Stat1−/− mice) (Mohan et al., 2000).
Derivation of a full-length molecular clone from faecal RNA
The full-length sequence of MNV from a WT mouse (MNV-O1) was obtained using primer 
walking, and used to design primers at the 5′ and 3′ ends of the genome (forward primer 
atagtttaggactagttaatacgactcactatagtgaaatgaggatggcaacgccatcttctgcgccc; reverse primer 
tcgcgaactagttttttttttttttttttttttttttaaaatgcatctaaatactactaaaagaaaagcagt). Using these primers, a 
full-length cDNA was derived directly from RNA extracted from a faecal sample obtained 
from an infected Stat1−/− mouse (MNV-O7). RNA was reverse transcribed using random 
hexamers and SuperScript III (Invitrogen), and the PCR used the Roche Applied Science 
Long Ranger PCR Kit.
Sequence analysis
Viral nucleotide sequences obtained (GenBank accession nos. KF113527 and KF113526 for 
MNV-O1 and MNV-O7, respectively) and their predicted amino acid sequences were 
aligned using Clustal W with full-length MNV genomic or protein sequences drawn from 
GenBank. A PhyML (Guindon et al., 2010) phylogenetic tree was constructed using 
SeaView software with 100 bootstrap repetitions (http://pbil.univ-lyon1.fr/software/
seaview.html; Gouy et al., 2010). The tree was then edited using FigTree software (http://
tree.bio.ed.ac.uk/software/figtree; Andrew Rambaut, Institute of Evolutionary Biology, 
University of Edinburgh, UK).
Reverse genetics
The full-length MNV-O7 cDNA clone was inserted into pT73′Rz to generate pT7-MNV-O7-
Rz carrying the O7 sequence under the control of a T7 RNA polymerase promoter. Using 
site-directed mutagenesis, the SpeI restriction site sequence on the 3′ primer was altered to a 
NheI restriction site sequence and the plasmid used to recover infectious virus as described 
previously (Chaudhry et al., 2007). Molecular clones of MNV-1.CW1, MNV-3, PIb 
(infectious MNV-1 produced by reverse genetics) and FS (MNV-1 construct with a 
frameshift) were used as controls (Arias et al., 2012; Chaudhry et al., 2007).
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Virus culture and quantification
MNV-1.CW3 was kindly provided by Professor H. Virgin (Department of Pathology and 
Immunology, Washington State University, USA) and is not persistent in WT mice, but is 
pathogenic in Stat1−/− mice (Mumphrey et al., 2007). MNV-O7 was cultured from 
homogenized faecal samples from a Stat1−/− mouse grown on RAW264.7 cells for 4 days, 
and the clarified supernatant taken after freeze–thawing and filtering through a 0.22 μm 
filter, and stored at −80 °C. MNV-O7 was amplified briefly by one passage on RAW264.7 
cells. MNV was used to infect RAW264.7 cells at a multiplicity of 0.1 TCID50 cell−1. Cells 
were incubated at 37 °C until CPEs approached 100 % or after 3–4 days if CPEs were not 
obvious. The virus was harvested and stored as above. Virus titre was determined by 
measuring TCID50 in RAW264.7 cells (if the virus induced CPEs) or by qRT-PCR.
To quantify the amount of virus in mouse faeces, tissues or cell culture, a real-time RT-
qPCR was performed using a dual-labelled probe (forward primer, FQ2: 
cgctgcgccatcactcatc; reverse primer, RQ2: gctttggaacaatggatgctgag; probe2: FAM-
ccgcaggaacgctcagcagtctt-BHQ1). RNA was extracted using the Roche Applied Science 
High Pure Viral RNA Kit and reverse transcribed as above. One-tenth of the cDNA reaction 
was used in the real-time PCR with Quantitect Probe PCR Master Mix using the 
manufacturer’s suggested primer and probe concentrations, and the PCR performed in a 
Rotor-Gene 6000 (Qiagen): Taq activation (15 min, 95 °C); PCR 40 cycles: 10 s, 95 °C, 30 
s, 60 °C; in triplicate. A standard curve was made using MNV-O7 cDNA cut from pT7-
MNV-O7-Rz using SpeI and NheI. The gel-purified DNA was diluted in 10 μg carrier RNA 
(yeast tRNA; Roche Applied Science) ml−1 in water to obtain 5×1011 to 5 molecules μl−1. 
The assay was validated using these DNA standards and RNA dilutions from infected tissue 
culture. Data were analysed using the Rotor-Gene 6000 series software 1.7 (Qiagen). The 
efficiency of the RT-qPCR for both RNA and DNA standard curves was unity. The range of 
the assay was 50 to 5×1010 copies per reaction.
ELISA for antibodies
Diagnostic MNV ELISA microtitre plates (Charles River Laboratories) were used as per the 
manufacturer’s instructions with 50 μl serum diluted 1: 60 (derived from a test serum 
titration). Positive and negative (CL550 and CL500, respectively; Charles River 
Laboratories) serum controls were used with each ELISA plate.
Animals and in vivo infections
Stat1 knockout (129S6/SvEv-Stat1tm1Rds, here Stat1−/−), WT (129S6/SvEv) and 
heterozygous mice were obtained originally from Taconic Farms. A small mix-breed group 
of animals from the John Radcliffe Hospital, University of Oxford was shipped to 
Cambridge for further study. The mice had no history of clinical disease and were free of 
known murine pathogens as listed on the Federation of European Laboratory Animal 
Science Associations guidelines (Nicklas et al., 2002) with the exception of MNV. The mice 
were ear biopsied for identification purposes and the biopsies used to extract DNA for 
genotyping (see above). From the mixed group, mice were rederived, genotyped and bred to 
homozygosity for the Stat1 gene deletion. Similarly, Stat1-positive animals were bred to 
homozygosity to use as WT immunocompetent animals. For experimental infections, mice 
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were used at 8–12 weeks of age and were negative for anti-MNV antibody by ELISA. The 
mice were housed in individually ventilated cages, and fed sterilized water and diet. 
Housing, care and procedures were carried out in compliance with the University ethical 
review process and the Animals (Scientific Procedures) Act 1986. Animals were inoculated 
with virus by oral gavage. Faecal samples were collected from individual mice.
Gross pathology
The following tissues were examined for gross lesions: intestine, mesenteric lymph node, 
spleen, liver and lung. The liver, spleen and lung were measured by ruler and digital images 
taken.
Histopathology
Small pieces of the small intestine (duodenum, jejunum and ileum), caecum, colon, 
mesenteric lymph node, spleen, liver and lung were placed in 10 % buffered formal saline 
and embedded in paraffin. Haematoxylin and eosin-stained 3 μm thick sections were viewed 
with a Carl Zeiss AxioVision microscope, the images captured using an AxioCam camera 
and processed using the AxioVision digital image processing software and/or the sections 
captured with a digital slide scanner Hamamatsu NanoZoomer 2.0 RS and the images 
viewed with NDP.view2.
The tissues were graded for the degree of inflammation, fibrosis and necrosis using a 
modification of published grading systems (Hübscher, 1998; Theise, 2007; Wirtz et al., 
2007) (Table S1, 10 fields per section were scored). The following were used: in the liver, 
hepatitis characterized by focal or multifocal infiltration of inflammatory cells mainly 
composed of mononuclear cells, macrophage-like cells and neutrophils with or without 
associated necrosis and/or fibrosis; in the lungs, pneumonia with focal or multifocal 
infiltration of mononuclear cells, macrophage-like cells and neutrophils in alveoli and 
alveolar walls with or without associated necrosis and/or fibrosis; in the mesenteric lymph 
node, activation, necrosis and/or fibrosis; in the blood vessel, vasculitis with adhesions of 
mononuclear cells and leukocytes to hepatic and pulmonary veins; in the spleen, activation, 
necrosis and/or fibrosis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
ACKNOWLEDGEMENTS
A. S. was supported by a fellowship from the Veterinary Training and Research Initiative programme at the 
University of Cambridge (Department for Environment, Food and Rural Affairs/Higher Education Funding Council 
of England grant no. VT0105). J. C. was supported by the Wellcome Trust 4-Year Infection and Immunity PhD 
Programme, University of Cambridge (grant no. 089214/Z/09/Z). We would like to thank Dr Miren Iturizza-
Gomara (Institute of Infection and Global Health, University of Liverpool, UK) for advice on RNA extraction from 
faecal samples, Dr Mariana Varela for advice on amplifying the full-length clone, Mr Paul Tonks for help with 
animal studies and Ms Julia Weinelt for help in genotyping mice.
Shortland et al. Page 11
J Gen Virol. Author manuscript; available in PMC 2015 January 29.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
REFERENCES
Agrawal S, Febbraio M, Podrez E, Cathcart MK, Stark GR, Chisolm GM. Signal transducer and 
activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion 
development. Circulation. 2007; 115:2939–2947. [PubMed: 17533179] 
Arias A, Bailey D, Chaudhry Y, Goodfellow I. Development of a reverse-genetics system for murine 
norovirus 3: long-term persistence occurs in the caecum and colon. J Gen Virol. 2012; 93:1432–
1441. [PubMed: 22495235] 
Bailey D, Thackray LB, Goodfellow IG. A single amino acid substitution in the murine norovirus 
capsid protein is sufficient for attenuation in vivo. J Virol. 2008; 82:7725–7728. [PubMed: 
18495770] 
Capizzi T, Makari-Judson G, Steingart R, Mertens WC. Chronic diarrhea associated with persistent 
norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases. BMC Infect 
Dis. 2011; 11:131. [PubMed: 21586142] 
Chachu KA, LoBue AD, Strong DW, Baric RS, Virgin HW. Immune mechanisms responsible for 
vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog. 
2008a; 4:e1000236. [PubMed: 19079577] 
Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW IV. Antibody is critical for the 
clearance of murine norovirus infection. J Virol. 2008b; 82:6610–6617. [PubMed: 18417579] 
Chaudhry Y, Skinner MA, Goodfellow IG. Recovery of genetically defined murine norovirus in tissue 
culture by using a fowlpox virus expressing T7 RNA polymerase. J Gen Virol. 2007; 88:2091–
2100. [PubMed: 17622609] 
Coyne KP, Dawson S, Radford AD, Cripps PJ, Porter CJ, McCracken CM, Gaskell RM. Long-term 
analysis of feline calicivirus prevalence and viral shedding patterns in naturally infected colonies of 
domestic cats. Vet Microbiol. 2006; 118:12–25. [PubMed: 16911860] 
Coyne KP, Gaskell RM, Dawson S, Porter CJ, Radford AD. Evolutionary mechanisms of persistence 
and diversification of a calicivirus within endemically infected natural host populations. J Virol. 
2007; 81:1961–1971. [PubMed: 17151126] 
Forrester NL, Boag B, Moss SR, Turner SL, Trout RC, White PJ, Hudson PJ, Gould EA. Long-term 
survival of New Zealand rabbit haemorrhagic disease virus RNA in wild rabbits, revealed by RT-
PCR and phylogenetic analysis. J Gen Virol. 2003; 84:3079–3086. [PubMed: 14573812] 
Forrester NL, Moss SR, Turner SL, Schirrmeier H, Gould EA. Recombination in rabbit haemorrhagic 
disease virus: possible impact on evolution and epidemiology. Virology. 2008; 376:390–396. 
[PubMed: 18455748] 
Gil MP, Bohn E, O’Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD. Biologic 
consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A. 2001; 98:6680–
6685. [PubMed: 11390995] 
Godinez I, Raffatellu M, Chu H, Paixão TA, Haneda T, Santos RL, Bevins CL, Tsolis RM, Baümler 
AJ. Interleukin-23 orchestrates mucosal responses to Salmonella enterica serotype Typhimurium 
in the intestine. Infect Immun. 2009; 77:387–398. [PubMed: 18955477] 
Gouy M, Guindon S, Gascuel O. SeaView version 4: a multiplatform graphical user interface for 
sequence alignment and phylogenetic tree building. Mol Biol Evol. 2010; 27:221–224. [PubMed: 
19854763] 
Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New algorithms and 
methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. 
Syst Biol. 2010; 59:307–321. [PubMed: 20525638] 
Hsu CC, Riley LK, Wills HM, Livingston RS. Persistent infection with and serologic cross-reactivity 
of three novel murine noroviruses. Comp Med. 2006; 56:247–251. [PubMed: 16941951] 
Hsu CC, Riley LK, Livingston RS. Molecular characterization of three novel murine noroviruses. 
Virus Genes. 2007; 34:147–155. [PubMed: 17171545] 
Hübscher SG. Histological grading and staging in chronic hepatitis: clinical applications and problems. 
J Hepatol. 1998; 29:1015–1022. [PubMed: 9875653] 
Johnson RP. Antigenic change in feline calicivirus during persistent infection. Can J Vet Res. 1992; 
56:326–330. [PubMed: 1335833] 
Shortland et al. Page 12
J Gen Virol. Author manuscript; available in PMC 2015 January 29.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Kahan SM, Liu G, Reinhard MK, Hsu CC, Livingston RS, Karst SM. Comparative murine norovirus 
studies reveal a lack of correlation between intestinal virus titers and enteric pathology. Virology. 
2011; 421:202–210. [PubMed: 22018636] 
Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW IV. STAT1-dependent innate immunity to a 
Norwalk-like virus. Science. 2003; 299:1575–1578. [PubMed: 12624267] 
Katpally U, Wobus CE, Dryden K, Virgin HW IV, Smith TJ. Structure of antibody-neutralized murine 
norovirus and unexpected differences from viruslike particles. J Virol. 2008; 82:2079–2088. 
[PubMed: 18094184] 
Lochridge VP, Hardy ME. A single-amino-acid substitution in the P2 domain of VP1 of murine 
norovirus is sufficient for escape from antibody neutralization. J Virol. 2007; 81:12316–12322. 
[PubMed: 17804495] 
Malmgaard L, Salazar-Mather TP, Lewis CA, Biron CA. Promotion of alpha/beta interferon induction 
during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and 
-independent pathways. J Virol. 2002; 76:4520–4525. [PubMed: 11932417] 
Manuel CA, Hsu CC, Riley LK, Livingston RS. Soiled-bedding sentinel detection of murine norovirus 
4. J Am Assoc Lab Anim Sci. 2008; 47:31–36. [PubMed: 18459710] 
McFadden N, Arias A, Dry I, Bailey D, Witteveldt J, Evans DJ, Goodfellow I, Simmonds P. Influence 
of genome-scale RNA structure disruption on the replication of murine norovirus – similar 
replication kinetics in cell culture but attenuation of viral fitness in vivo. Nucleic Acids Res. 2013; 
41:6316–6331. [PubMed: 23630317] 
Mohan RR, Mohan RR, Kim WJ, Stark GR, Wilson SE. Defective keratocyte apoptosis in response to 
epithelial injury in Stat 1 null mice. Exp Eye Res. 2000; 70:485–491. [PubMed: 10865997] 
Mumphrey SM, Changotra H, Moore TN, Heimann-Nichols ER, Wobus CE, Reilly MJ, 
Moghadamfalahi M, Shukla D, Karst SM. Murine norovirus 1 infection is associated with 
histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-
dependent interferon responses. J Virol. 2007; 81:3251–3263. [PubMed: 17229692] 
Nice TJ, Strong DW, McCune BT, Pohl CS, Virgin HW. A single-amino-acid change in murine 
norovirus NS1/2 is sufficient for colonic tropism and persistence. J Virol. 2013; 87:327–334. 
[PubMed: 23077309] 
Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, Illgen-Wilcke B, FELASA 
(Federation of European Laboratory Animal Science Associations Working Group on Health 
Monitoring of Rodent and Rabbit Colonies). Recommendations for the health monitoring of rodent 
and rabbit colonies in breeding and experimental units. Lab Anim. 2002; 36:20–42. [PubMed: 
11831737] 
Oldstone MB. Viral persistence: parameters, mechanisms and future predictions. Virology. 2006; 
344:111–118. [PubMed: 16364742] 
Radford AD, Turner PC, Bennett M, McArdle F, Dawson S, Glenn MA, Williams RA, Gaskell RM. 
Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell 
culture and in persistently infected cats. J Gen Virol. 1998; 79:1–10. [PubMed: 9460915] 
Ramana CV, Gil MP, Schreiber RD, Stark GR. Stat1-dependent and -independent pathways in IFN-
gamma-dependent signaling. Trends Immunol. 2002; 23:96–101. [PubMed: 11929133] 
Shresta S, Sharar KL, Prigozhin DM, Snider HM, Beatty PR, Harris E. Critical roles for both STAT1-
dependent and STAT1-independent pathways in the control of primary dengue virus infection in 
mice. J Immunol. 2005; 175:3946–3954. [PubMed: 16148142] 
Siebenga JJ, Beersma MF, Vennema H, van Biezen P, Hartwig NJ, Koopmans M. High prevalence of 
prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo 
molecular evolution. J Infect Dis. 2008; 198:994–1001. [PubMed: 18774885] 
Taube S, Rubin JR, Katpally U, Smith TJ, Kendall A, Stuckey JA, Wobus CE. High-resolution x-ray 
structure and functional analysis of the murine norovirus 1 capsid protein protruding domain. J 
Virol. 2010; 84:5695–5705. [PubMed: 20335262] 
Thackray LB, Wobus CE, Chachu KA, Liu B, Alegre ER, Henderson KS, Kelley ST, Virgin HW IV. 
Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited 
sequence divergence. J Virol. 2007; 81:10460–10473. [PubMed: 17652401] 
Shortland et al. Page 13
J Gen Virol. Author manuscript; available in PMC 2015 January 29.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Theise ND. Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Mod 
Pathol. 2007; 20(Suppl 1):S3–S14. [PubMed: 17486049] 
Tomov VT, Osborne LC, Dolfi DV, Sonnenberg GF, Monticelli LA, Mansfield K, Virgin HW, Artis 
D, Wherry EJ. Persistent enteric murine norovirus infection is associated with functionally 
suboptimal virus-specific CD8 T cell responses. J Virol. 2013; 87:7015–7031. [PubMed: 
23596300] 
Ward JM, Wobus CE, Thackray LB, Erexson CR, Faucette LJ, Belliot G, Barron EL, Sosnovtsev SV, 
Green KY. Pathology of immunodeficient mice with naturally occurring murine norovirus 
infection. Toxicol Pathol. 2006; 34:708–715. [PubMed: 17074739] 
Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal 
inflammation. Nat Protoc. 2007; 2:541–546. [PubMed: 17406617] 
Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G, Krug A, Mackenzie JM, 
Green KY, Virgin HW. Replication of Norovirus in cell culture reveals a tropism for dendritic 
cells and macrophages. PLoS Biol. 2004; 2:e432. [PubMed: 15562321] 
Shortland et al. Page 14
J Gen Virol. Author manuscript; available in PMC 2015 January 29.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Fig. 1. 
MNV phylogenetic tree including MNV-O7 and pathology caused by natural infection. (a) 
Full-length genomic MNV nucleotide sequences were used to construct a maximum-
likelihood phylogenetic tree with PhyML and 100 bootstrap interactions. The bootstrap 
values are indicated on the branches. Bar, 2 % nucleotide divergence. (b–d) Representative 
pathology in liver (b, c) and lung (d) sections from naturally infected Stat1−/− mice from 
which MNV-O7 was derived. (b) A focus of inflammation in the liver parenchyma that is 
magnified in (c) to show the presence of inflammatory cells (macrophages shown by the 
white arrow) and necrotic (black arrow) cells. (d) General infiltration of the lung; the arrow 
indicates a localized focus of inflammation associated with a bronchiole and blood vessel. 
Original magnification, ×10 (b, d) and ×40 (c).
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Fig. 2. 
Percentage body weight change in mice infected with MNV. Mice (n=8) were mock-
infected or infected with 108 copies of MNV RNA by oral gavage on day 0, and the body 
weight change scored daily and then weekly (medians shown). Circles, MNV-1.CW3; 
squares, MNV-O7; triangles, mock-infected mice; open symbols, WT mice; closed symbols, 
Stat1−/− mice. P-values were determined using one-way ANOVA and Dunnet’s post tests to 
compare between groups in the same genetic background; **P<0.01. Bars, SD.
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Fig. 3. 
Liver and spleen pathology in Stat1−/− mice infected with MNV-O7mc. Examples of liver 
and spleen pathology seen in mock- and MNV-O7mc (104 RNA copies by oral gavage)-
infected Stat1−/− mice at day 7 p.i. (a, c) Normal tissue architecture in mock-inoculated 
animals. (b) A general increase in inflammatory cells and prominent cannuli. (d) An area of 
coagulative necrosis and pyknotic debris suggestive of apoptosis. Original magnification, 
×20; bar, 300 μm.
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Fig. 4. 
Histopathology in livers during acute MNV infection. Haematoxylin & eosin-stained liver 
sections from mock (a, d) or infected mice (108 RNA copies by oral gavage) at day 5 p.i. 
[MNV-O7 (b, e) and MNV-1 (c, f)]; infected WT (a–c) and Stat1−/− (d–f) mice are shown. 
Original magnification, ×20 bar, 300 μm.
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Fig. 5. 
Histopathology in livers during chronic MNV infection. Haematoxylin & eosin-stained liver 
sections from mock (a, d) or infected mice (108 RNA copies by oral gavage) at day 54 p.i. 
[MNV-O7 (b, e) and MNV-1 (c)]; infected WT (a–c) and Stat1−/− (d, e) mice are shown. 
Original magnification, ×20 bar, 300 μm.
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Fig. 6. 
Histopathological grading of liver pathology from MNV-infected mice. Liver 
histopathology was scored (see Table S1 for scoring system) after (a) acute (day 7 p.i.) and 
(b) chronic (day 54 p.i.) infection (108 RNA copies by oral gavage). Individual mouse scores 
and group medians are shown. Statistical analysis used a Mann–Whitney test; *P<0.01 and 
**P<0.001 comparing an infected group to the mock-infected group.
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Table 1
Diagnostic viral RT-PCRs of tissue and faecal samples from MNV-infected mice
Day p.i. Tissue Mouse type Inoculum
Medium MNV-O7 MNV-1
5 Faeces Stat1 −/− 0/8 8/8 8/8
WT 0/8 8/8 8/8
54 Faeces Stat1 −/− ND 0/5 NA
WT ND 4/4 0/4
54 Liver Stat1 −/− ND 2/4 NA
WT ND 4/4 0/4
54 Spleen Stat1 −/− ND 3/4 NA
WT ND 4/4 0/4
ND, Not done; NA, not applicable.
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